Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone luteal support in unexplained infertility management
2026-525747-33-00Phase 4Authorised
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Unexplained infertility comparing Utrogestan luteal support with Placebo (2 arms). Primary endpoint: Live birth within 6 months after randomisation. Planned start Jun 2026; status: authorised.
02
Drugs
progesterone
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on 2026-525747-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525747-33-00.